🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Harkaa Keessummaa › Tennessee

Qorannoo klinikaalii Dhibee Harkaa Keessummaa Tennessee keessatti

Qorannoo 14 Dhibee Harkaa Keessummaa f Tennessee keessatti hirmaatuu jiru.

Magaalota Tennessee keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #4, Chattanooga
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07268638

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Chattanooga
  • Research Site, Knoxville
  • Research Site, Knoxville
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06742723

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Chattanooga
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07624305

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  • University of Tennessee Health Science Center- Le Bonheur Research Center, Memphis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 18 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07498335

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Vanderbilt University Medical Center, Nashville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07107945

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Southeast Renal Research Institute, Chattanooga
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07271186

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Morristown
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07753993

Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)

  • Memphis VA Medical Center, Memphis, TN, Memphis
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT05465044

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • Knoxville Kidney Center Pllc, Brentwood
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06858319

Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

  • Vanderbilt University Medical Center, Nashville
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 21 hanga 85 · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT04984226

Empagliflozin Treatment in Kidney Transplant Recipients

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 21-Elb-2026 · NCT06013865

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

  • Vanderbilt University Medical Center, Nashville
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Elb-2026 · NCT07385651

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  • James Eric Gardner, MD, PC, Memphis
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT06001827

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

  • University of Tennessee Medical Center, Knoxville
  • University of Tennessee Health Science Center/Regional One Health, Memphis
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ama-2026 · NCT06374277

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.